Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29618381 | 1.00 | DYRK1A (0.36) | DYRK1ASMN1; SMN2MAPTRAB9AHTT | |
| SCHEMBL31168552 | 0.78 | DYRK1A (0.36) | DYRK1ASMN1; SMN2MAPTRAB9ANPC1 | |
| SCHEMBL31168524 | 0.78 | DYRK1A (0.36) | DYRK1ASMN1; SMN2MAPTRAB9A | |
| SCHEMBL31168471 | 0.76 | MAPT (0.35) | DYRK1ASMN1; SMN2MAPTRAB9AHTT | |
| SCHEMBL24517473 | 0.74 | KDM4E (0.40) | DYRK1ASMN1; SMN2RAB9AHTTKMT2A | |
| SCHEMBL29618324 | 0.74 | KDM4E (0.40) | DYRK1ASMN1; SMN2RAB9AHTTKMT2A | |
| SCHEMBL29664537 | 0.68 | HSP90AA1 (0.35) | HTTKMT2A | |
| SCHEMBL31168503 | 0.68 | ACHE (0.37) | DYRK1AALDH1A1 | |
| SCHEMBL31168469 | 0.68 | ACHE (0.37) | DYRK1AALDH1A1 | |
| SCHEMBL21333142 | 0.67 | DYRK1A (0.35) | DYRK1ASMN1; SMN2MAPTRAB9AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022121805-A1 | FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF | 成都康弘药业集团股份有限公司 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022121805-A1 | FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF | 成都康弘药业集团股份有限公司 | 2022-06-16 | — | — | WO | disclosed |
| CN-114591293-A | Fused ring compound as Nav1.8 inhibitor and application thereof | 成都康弘药业集团股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| WO-2020083377-A1 | PYRROLIDINYL UREA DERIVATIVES AND APPLICATION THEREOF | 南京明德新药研发有限公司 | 2020-04-30 | — | — | WO | disclosed |